Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
82,282,268
-
Share change
-
-1,875,304
-
Total reported value
-
$3,929,380,654
-
Put/Call ratio
-
28%
-
Price per share
-
$47.76
-
Number of holders
-
193
-
Value change
-
-$83,608,659
-
Number of buys
-
120
-
Number of sells
-
65
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2015
As of 30 Jun 2015,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,282,268 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, BB BIOTECH AG, BlackRock Fund Advisors, PointState Capital LP, Invesco Ltd., and STATE STREET CORP.
This page lists
191
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.